DFTX

Definium Therapeutics, Inc. Common Shares

16.79

USD

DFTX Earnings Reports

Positive Surprise Ratio

No Data Available for DFTX

Next Report

Date of Next Report

Mar 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.51

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

+24.39%

Definium Therapeutics, Inc. Common Shares earnings per share and revenue

On --, DFTX reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, -- analysts forecast an EPS of -0.51 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

WaFd, Inc. Depositary Shares

Report Date

Jan 15, 2026 For Q1 26

Estimate

$0.76

Actual

$0.79

Surprise

+2.85%

FAQ

What were Definium Therapeutics, Inc. Common Shares's earnings and revenue for the latest quarter Q-- --?

For Q-- --, Definium Therapeutics, Inc. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Definium Therapeutics, Inc. Common Shares's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Definium Therapeutics, Inc. Common Shares expected to report next?

The next earning report is scheduled for Mar 04, 2026.

What are the forecasts for Definium Therapeutics, Inc. Common Shares's next earnings report?

Based on -- analysts, Definium Therapeutics, Inc. Common Shares is expected to report EPS of -$0.51 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.